ADENOID CYSTIC CARCINOMA

Clinical trials for ADENOID CYSTIC CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new ADENOID CYSTIC CARCINOMA trials appear

Sign up with your email to follow new studies for ADENOID CYSTIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 8 Not yet recruiting 1 Not yet finished but already full! 4 Completed 1 Terminated 2

New hope for rare, aggressive head and neck cancer

Disease control Not yet recruiting

This study is testing a new drug called puxitatug samrotecan (AZD8205) in patients with an aggressive form of a rare salivary gland cancer called adenoid cystic carcinoma that has returned or spread. The main goals are to see if the drug shrinks tumors and is safe for patients. T…

Matched conditions: ADENOID CYSTIC CARCINOMA

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 17, 2026 13:09 UTC

ADENOID CYSTIC CARCINOMA

Get alerted when new ADENOID CYSTIC CARCINOMA trials appear

New hope for rare, aggressive head and neck cancer